@article{15d337f008954a1ca6ba77db249c3c5c,
title = "Pharmacogenetic Information in Clinical Guidelines: The European Perspective",
abstract = " Surveys among pharmacists and physicians show that these healthcare professionals have successfully adopted the concept of pharmacogenomics (PGx). 1-3 In addition, patients are willing to consent to participate in PGx implementation studies. 4 However, the surveys also show that healthcare professionals do not frequently order or recommend a PGx test. 1,2 Among others, a frequently perceived hurdle for clinical uptake of PGx is the availability of guidelines translating PGx test results into clinical actions for individual patients. 5,6 . ",
author = "Swen, \{Jesse J.\} and Marga Nijenhuis and \{van Rhenen\}, Mandy and \{de Boer-Veger\}, \{Nienke J.\} and Buunk, \{Anne Marie\} and Houwink, \{Elisa J.F.\} and Hans Mulder and Rongen, \{Gerard A.\} and \{van Schaik\}, \{Ron H.N.\} and \{van der Weide\}, Jan and Bob Wilffert and Deneer, \{Vera H.M.\} and Guchelaar, \{Henk Jan\}",
note = "Funding Information: Funding was received from the European Community{\textquoteright}s Horizon 2020 Programme. Grant No. 668353. Funding Information: Funding was received from the European Community's Horizon 2020 Programme. Grant No. 668353. Publisher Copyright: {\textcopyright} 2018 American Society for Clinical Pharmacology and Therapeutics",
year = "2018",
month = may,
day = "1",
doi = "10.1002/cpt.1049",
language = "English",
volume = "103",
pages = "795--801",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Wiley-Blackwell",
number = "5",
}